Mentoring Gender, Selecting Sex
By Osagie Obasogie,
Boston Globe
| 08. 08. 2005
It's a boy! It's a girl! Until the 1970s, these words welcomed virtually every child into the world. In less than one generation, however, new reproductive technologies have shifted this announcement from the delivery room to the obstetricians' office; ultrasounds and amniocenteses now allow expecting parents to choose their nursery walls' paint color months before giving birth.
The science and business of sex identification took yet another quantum leap forward this past week with the Pregnancystore.com's release of the Baby Gender Mentor Home DNA Gender Testing Kit. Now, a woman can know her child's sex shortly after she discovers her pregnancy. As soon as five weeks after conception, she can prick her finger, FedEx a blood sample to Acu-Gen Biolab in Lowell, MA, and have the sex of her sprouting embryo emailed to her faster than Netflix can send her next movie.
An unequivocal good, many say. What's more harmless than learning whether to buy dolls or trucks for the toy chest?
Ultrasounds and amniocenteses cannot accurately determine a fetus' sex until at least four months into pregnancy and sometimes...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Susanna Smith, Genetic Frontiers | 07.28.2025
Key Topics
How does the American far right view genetics and genetic technologies?
What is the history of the American cultural pursuit of trying to choose smarter children? What has science shown us about the relationship of heredity and intelligence...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...